1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antivenom Serum Consumption 2016-2026
2.1.2 Antivenom Serum Consumption CAGR by Region
2.2 Antivenom Serum Segment by Type
2.2.1 Humans
2.2.2 Animals
2.3 Antivenom Serum Sales by Type
2.3.1 Global Antivenom Serum Sales Market Share by Type (2016-2021)
2.3.2 Global Antivenom Serum Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antivenom Serum Sale Price by Type (2016-2021)
2.4 Antivenom Serum Segment by Application
2.4.1 Monovalent
2.4.2 Polyvalent
2.5 Antivenom Serum Sales by Application
2.5.1 Global Antivenom Serum Sale Market Share by Application (2016-2021)
2.5.2 Global Antivenom Serum Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antivenom Serum Sale Price by Application (2016-2021)
3 Global Antivenom Serum by Company
3.1 Global Antivenom Serum Sales Market Share by Company
3.1.1 Global Antivenom Serum Sales by Company (2019-2021)
3.1.2 Global Antivenom Serum Sales Market Share by Company (2019-2021)
3.2 Global Antivenom Serum Revenue Market Share by Company
3.2.1 Global Antivenom Serum Revenue by Company (2019-2021)
3.2.2 Global Antivenom Serum Revenue Market Share by Company (2019-2021)
3.3 Global Antivenom Serum Sale Price by Company
3.4 Global Manufacturers Antivenom Serum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antivenom Serum Product Location Distribution
3.4.2 Players Antivenom Serum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Antivenom Serum by Region
4.1 Global Antivenom Serum by Region
4.1.1 Global Antivenom Serum Sales by Region
4.1.2 Global Antivenom Serum Revenue by Region
4.2 Americas Antivenom Serum Sales Growth
4.3 APAC Antivenom Serum Sales Growth
4.4 Europe Antivenom Serum Sales Growth
4.5 Middle East & Africa Antivenom Serum Sales Growth
5 Americas
5.1 Americas Antivenom Serum Sales by Country
5.1.1 Americas Antivenom Serum Sales by Country (2016-2021)
5.1.2 Americas Antivenom Serum Revenue by Country (2016-2021)
5.2 Americas Antivenom Serum Sales by Type
5.3 Americas Antivenom Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antivenom Serum Sales by Region
6.1.1 APAC Antivenom Serum Sales by Region (2016-2021)
6.1.2 APAC Antivenom Serum Revenue by Region (2016-2021)
6.2 APAC Antivenom Serum Sales by Type
6.3 APAC Antivenom Serum Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antivenom Serum by Country
7.1.1 Europe Antivenom Serum Sales by Country (2016-2021)
7.1.2 Europe Antivenom Serum Revenue by Country (2016-2021)
7.2 Europe Antivenom Serum Sales by Type
7.3 Europe Antivenom Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antivenom Serum by Country
8.1.1 Middle East & Africa Antivenom Serum Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antivenom Serum Revenue by Country (2016-2021)
8.2 Middle East & Africa Antivenom Serum Sales by Type
8.3 Middle East & Africa Antivenom Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antivenom Serum Distributors
10.3 Antivenom Serum Customer
11 Global Antivenom Serum Market Forecast
11.1 Global Antivenom Serum Forecast by Region
11.1.1 Global Antivenom Serum Forecast by Regions (2021-2026)
11.2.2 Global Antivenom Serum Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Antivenom Serum Forecast by Type
11.7 Global Antivenom Serum Forecast by Application
12 Key Players Analysis
12.1 Merck
12.1.1 Merck Merck Company Information
12.1.2 Merck Antivenom Serum Product Offered
12.1.3 Merck Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 Summerland Serums (AU)
12.2.1 Summerland Serums (AU) Company Information
12.2.2 Summerland Serums (AU) Antivenom Serum Product Offered
12.2.3 Summerland Serums (AU) Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Summerland Serums (AU) Main Business Overview
12.2.5 Summerland Serums (AU) Latest Developments
12.3 Haffkine Bio Pharmaceutical
12.3.1 Haffkine Bio Pharmaceutical Company Information
12.3.2 Haffkine Bio Pharmaceutical Antivenom Serum Product Offered
12.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Haffkine Bio Pharmaceutical Main Business Overview
12.3.5 Haffkine Bio Pharmaceutical Latest Developments
12.4 MicroPharm
12.4.1 MicroPharm Company Information
12.4.2 MicroPharm Antivenom Serum Product Offered
12.4.3 MicroPharm Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 MicroPharm Main Business Overview
12.4.5 MicroPharm Latest Developments
12.5 CSL (AU)
12.5.1 CSL (AU) Company Information
12.5.2 CSL (AU) Antivenom Serum Product Offered
12.5.3 CSL (AU) Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CSL (AU) Main Business Overview
12.5.5 CSL (AU) Latest Developments
12.6 SAVP
12.6.1 SAVP Company Information
12.6.2 SAVP Antivenom Serum Product Offered
12.6.3 SAVP Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 SAVP Main Business Overview
12.6.5 SAVP Latest Developments
12.7 Flynn Pharma
12.7.1 Flynn Pharma Company Information
12.7.2 Flynn Pharma Antivenom Serum Product Offered
12.7.3 Flynn Pharma Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Flynn Pharma Main Business Overview
12.7.5 Flynn Pharma Latest Developments
12.8 Serum
12.8.1 Serum Company Information
12.8.2 Serum Antivenom Serum Product Offered
12.8.3 Serum Antivenom Serum Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Serum Main Business Overview
12.8.5 Serum Latest Developments
13 Research Findings and Conclusion
List of TablesTable 1. Antivenom Serum Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Humans
Table 3. Major Players of Animals
Table 4. Global Antivenom Serum Sales by Type (2016-2021) & (K Doses)
Table 5. Global Antivenom Serum Sales Market Share by Type (2016-2021)
Table 6. Global Antivenom Serum Revenue by Type (2016-2021) & ($ million)
Table 7. Global Antivenom Serum Revenue Market Share by Type (2016-2021)
Table 8. Global Antivenom Serum Sale Price by Type (2016-2021)
Table 9. Global Antivenom Serum Sales by Application (2016-2021) & (K Doses)
Table 10. Global Antivenom Serum Sales Market Share by Application (2016-2021)
Table 11. Global Antivenom Serum Value by Application (2016-2021)
Table 12. Global Antivenom Serum Revenue Market Share by Application (2016-2021)
Table 13. Global Antivenom Serum Sale Price by Application (2016-2021)
Table 14. Global Antivenom Serum Sales by Company (2019-2021) & (K Doses)
Table 15. Global Antivenom Serum Sales Market Share by Company (2019-2021)
Table 16. Global Antivenom Serum Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Antivenom Serum Revenue Market Share by Company (2019-2021)
Table 18. Global Antivenom Serum Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Antivenom Serum Producing Area Distribution and Sales Area
Table 20. Players Antivenom Serum Products Offered
Table 21. Antivenom Serum Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Antivenom Serum Sales by Region (2016-2021) (K Doses)
Table 25. Global Antivenom Serum Sales Market Share by Region (2016-2021)
Table 26. Global Antivenom Serum Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Antivenom Serum Revenue Market Share by Region (2016-2021)
Table 28. Americas Antivenom Serum Sales by Country (2016-2021) & (K Doses)
Table 29. Americas Antivenom Serum Sales Market Share by Country (2016-2021)
Table 30. Americas Antivenom Serum Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Antivenom Serum Revenue Market Share by Country (2016-2021)
Table 32. Americas Antivenom Serum Sales by Type (2016-2021) & (K Doses)
Table 33. Americas Antivenom Serum Sales Market Share by Type (2016-2021)
Table 34. Americas Antivenom Serum Sales by Application (2016-2021) & (K Doses)
Table 35. Americas Antivenom Serum Sales Market Share by Application (2016-2021)
Table 36. APAC Antivenom Serum Sales by Region (2016-2021) & (K Doses)
Table 37. APAC Antivenom Serum Sales Market Share by Region (2016-2021)
Table 38. APAC Antivenom Serum Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Antivenom Serum Revenue Market Share by Region (2016-2021)
Table 40. APAC Antivenom Serum Sales by Type (2016-2021) & (K Doses)
Table 41. APAC Antivenom Serum Sales Market Share by Type (2016-2021)
Table 42. APAC Antivenom Serum Sales by Application (2016-2021) & (K Doses)
Table 43. APAC Antivenom Serum Sales Market Share by Application (2016-2021)
Table 44. Europe Antivenom Serum Sales by Country (2016-2021) & (K Doses)
Table 45. Europe Antivenom Serum Sales Market Share by Country (2016-2021)
Table 46. Europe Antivenom Serum Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Antivenom Serum Revenue Market Share by Country (2016-2021)
Table 48. Europe Antivenom Serum Sales by Type (2016-2021) & (K Doses)
Table 49. Europe Antivenom Serum Sales Market Share by Type (2016-2021)
Table 50. Europe Antivenom Serum Sales by Application (2016-2021) & (K Doses)
Table 51. Europe Antivenom Serum Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Antivenom Serum Sales by Country (2016-2021) & (K Doses)
Table 53. Middle East & Africa Antivenom Serum Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Antivenom Serum Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Antivenom Serum Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Antivenom Serum Sales by Type (2016-2021) & (K Doses)
Table 57. Middle East & Africa Antivenom Serum Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Antivenom Serum Sales by Application (2016-2021) & (K Doses)
Table 59. Middle East & Africa Antivenom Serum Sales Market Share by Application (2016-2021)
Table 60. Global Antivenom Serum Sales Forecast by Type (2021-2026) & (K Doses)
Table 61. Global Antivenom Serum Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Antivenom Serum Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Antivenom Serum Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Antivenom Serum Sales Forecast by Application (2021-2026) & (K Doses)
Table 65. Global Antivenom Serum Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Antivenom Serum Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Antivenom Serum Revenue Market Share Forecast by Application (2021-2026)
Table 68. Merck Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 69. Merck Antivenom Serum Product Offered
Table 70. Merck Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 71. Merck Main Business
Table 72. Merck Latest Developments
Table 73. Summerland Serums (AU) Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 74. Summerland Serums (AU) Antivenom Serum Product Offered
Table 75. Summerland Serums (AU) Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 76. Summerland Serums (AU) Main Business
Table 77. Summerland Serums (AU) Latest Developments
Table 78. Haffkine Bio Pharmaceutical Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 79. Haffkine Bio Pharmaceutical Antivenom Serum Product Offered
Table 80. Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 81. Haffkine Bio Pharmaceutical Main Business
Table 82. Haffkine Bio Pharmaceutical Latest Developments
Table 83. MicroPharm Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 84. MicroPharm Antivenom Serum Product Offered
Table 85. MicroPharm Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 86. MicroPharm Main Business
Table 87. MicroPharm Latest Developments
Table 88. CSL (AU) Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL (AU) Antivenom Serum Product Offered
Table 90. CSL (AU) Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 91. CSL (AU) Main Business
Table 92. CSL (AU) Latest Developments
Table 93. SAVP Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 94. SAVP Antivenom Serum Product Offered
Table 95. SAVP Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 96. SAVP Main Business
Table 97. SAVP Latest Developments
Table 98. Flynn Pharma Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 99. Flynn Pharma Antivenom Serum Product Offered
Table 100. Flynn Pharma Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 101. Flynn Pharma Main Business
Table 102. Flynn Pharma Latest Developments
Table 103. Serum Basic Information, Antivenom Serum Manufacturing Base, Sales Area and Its Competitors
Table 104. Serum Antivenom Serum Product Offered
Table 105. Serum Antivenom Serum Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 106. Serum Main Business
Table 107. Serum Latest Developments
List of Figures
Figure 1. Picture of Antivenom Serum
Figure 2. Antivenom Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antivenom Serum Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Antivenom Serum Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Antivenom Serum Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Humans
Figure 10. Product Picture of Animals
Figure 11. Global Antivenom Serum Sales Market Share by Type in 2020
Figure 12. Global Antivenom Serum Revenue Market Share by Type (2016-2021)
Figure 13. Antivenom Serum Consumed in Monovalent
Figure 14. Global Antivenom Serum Market: Monovalent (2016-2021) & (K Doses)
Figure 15. Antivenom Serum Consumed in Polyvalent
Figure 16. Global Antivenom Serum Market: Polyvalent (2016-2021) & (K Doses)
Figure 17. Global Antivenom Serum Sales Market Share by Application (2016-2021)
Figure 18. Global Antivenom Serum Revenue Market Share by Application in 2020
Figure 19. Global Antivenom Serum Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Antivenom Serum Revenue Market Share by Company in 2020
Figure 21. Global Antivenom Serum Sales Market Share by Regions (2016-2021)
Figure 22. Global Antivenom Serum Revenue Market Share by Region in 2020
Figure 23. Americas Antivenom Serum Sales 2016-2021 (K Doses)
Figure 24. Americas Antivenom Serum Revenue 2016-2021 ($ Millions)
Figure 25. APAC Antivenom Serum Sales 2016-2021 (K Doses)
Figure 26. APAC Antivenom Serum Revenue 2016-2021 ($ Millions)
Figure 27. Europe Antivenom Serum Sales 2016-2021 (K Doses)
Figure 28. Europe Antivenom Serum Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Antivenom Serum Sales 2016-2021 (K Doses)
Figure 30. Middle East & Africa Antivenom Serum Revenue 2016-2021 ($ Millions)
Figure 31. Americas Antivenom Serum Sales Market Share by Country in 2020
Figure 32. Americas Antivenom Serum Revenue Market Share by Country in 2020
Figure 33. Americas Antivenom Serum Sales Market Share by Type in 2020
Figure 34. Americas Antivenom Serum Sales Market Share by Application in 2020
Figure 35. United States Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Antivenom Serum Sales Market Share by Region in 2020
Figure 40. APAC Antivenom Serum Revenue Market Share by Regions in 2020
Figure 41. APAC Antivenom Serum Sales Market Share by Type in 2020
Figure 42. APAC Antivenom Serum Sales Market Share by Application in 2020
Figure 43. China Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Antivenom Serum Sales Market Share by Country in 2020
Figure 50. Europe Antivenom Serum Revenue Market Share by Country in 2020
Figure 51. Europe Antivenom Serum Sales Market Share by Type in 2020
Figure 52. Europe Antivenom Serum Sales Market Share by Application in 2020
Figure 53. Germany Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Antivenom Serum Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Antivenom Serum Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Antivenom Serum Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Antivenom Serum Sales Market Share by Application in 2020
Figure 62. Egypt Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Antivenom Serum Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
【免責事項】
https://www.globalresearch.jp/disclaimer